Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

This study has been completed.
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston Identifier:
First received: January 21, 2009
Last updated: October 1, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)